Document:

Exhibit 10.1

 

INSTRUCTIONS TO PROSPECTIVE INVESTORS

OF

FLUX POWER HOLDINGS, INC.,

a Nevada corporation

 

After you have reviewed the Subscription
Agreement ("Subscription Agreement"), and you wish to complete the proposed transaction, take the following actions with
respect to the documents set forth below (the "Transaction Documents"):

 

		1.	Please sign the Subscription Agreement.

 

		2.	Please complete the Investor Suitability Questionnaire.

  

     

     

    

‎

FLUX POWER HOLDINGS, INC.

SUBSCRIPTION AGREEMENT

 

THIS SUBSCRIPTION AGREEMENT
(this “Agreement”), dated April 28, 2016, is entered into by and between Flux Power Holdings, Inc., a Nevada
corporation (the “Company”), and the person or entity executing the Agreement (the “Investor”).
In this Agreement, the pronoun “it” means “he, “she,” or “it,” as appropriate.

 

A.The Company
is offering to selected “accredited investors” up to 77,500,000 shares of the Company’s Common Stock, par value
$0.001 (“Shares”) for aggregate amount of $3,100,000, or $0.04 per Share (the “Offering”),
subject to the terms, conditions, acknowledgements, representations, and warranties stated herein; however, the Company reserves
the right to accept subscriptions for lesser amounts as well as the right to reject in whole or in part subscriptions received
during the Offering.

 

B.The Company and
the Investor are executing and delivering this Agreement in reliance upon the exemption from registration afforded by Section 4(a)(2)
of the Securities Act of 1933, as amended (the “Securities Act”), and Rule 506 of Regulation D (“Regulation
D”) as promulgated by the United States Securities and Exchange Commission (the “SEC”) under the Securities
Act.

 

C.As part of this
Offering, Esenjay Investments LLC (“Esenjay”), a controlling shareholder of the Company which owns approximately
65% of the Company’s issued and outstanding common stock and our primary credit line holder, has agreed to purchase an aggregate
of 33,750,000 Shares in exchange for forgiveness of debt owed to Esenjay by the Company’s wholly-owned subsidiary, Flux Power,
Inc., in the amount of $1,350,000 (“Outstanding Debt”).

 

NOW, THEREFORE, IN
CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and
adequacy of which are hereby acknowledged, the Company and the Investor agree as follows:

 

ARTICLE I

DEFINITIONS

 

1.Definitions.
In addition to the terms defined elsewhere in this Agreement, the following terms have the meanings indicated:

 

“Aggregate Purchase Price”
means the product of the aggregate number of Shares subscribed by the Investor under this Agreement and purchase price of $0.04
per Share.

 

“Agreement” has the meaning set
forth in the Preamble.

 

“Business
Day” means any day other than Saturday, Sunday, any day which shall be a federal legal holiday in the United States or
any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to
close.

 

“Company” has the meaning
set forth in the Preamble.

 

“Common Stock” means common stock
of the Company, par value $0.001.

 

“Disclosure
Materials” means the SEC Documents and this Agreement.

 

“Exchange Act” means
the Securities Exchange Act of 1934, as amended.

 

    	 	 1	 

     

    

 

“Investor” has the meaning
set forth in the Preamble.

 

“Investor
Suitability Questionnaire” means the Investor Suitability Questionnaire, in substantially set forth herein as “Exhibit
A” as completed and executed by the Investor.

 

“Material
Adverse Effect” means (i) a material adverse effect on the results of operations, assets, business, prospects or financial
condition of the Company or (ii) material and adverse impairment of the Company’s ability to perform its obligations under
any of the Transaction Documents.

 

“Regulation D”
has the meaning set forth in the Preamble.

 

“Rule 144,”
“Rule 415,” and “Rule 424” means Rule 144, Rule 415 and Rule 424, respectively, promulgated
by the SEC pursuant to the Securities Act, as such Rules may be amended from time to time, or any similar rule or regulation hereafter
adopted by the SEC having substantially the same effect as such Rule.

 

“SEC” means the United
States Securities and Exchange Commission.

 

“SEC Documents” has the
meanings set forth in Section 3.4.

 

“Securities Act” has
the meaning set forth in the Recitals.

 

“Shares” means
shares of the Company’s Common Stock.

 

“Transaction
Documents” means this Agreement, the schedules and exhibits attached hereto, including but not limited to the Investor
Suitability Questionnaire.

 

ARTICLE II

PURCHASE AND SALE

 

2.Offering and Purchase of the Shares.

 

2.1Offering.
The Company is offering to sell up to 77,500,000 Shares for aggregate amount of $3,100,000 (“Offering Amount”),
or $0.04 per Share (the “Offering”). The Company has the sole discretion to increase the Offering Amount. The
minimum investment amount in this Offering per Investor is $25,000, however, the Company reserves the right to accept subscriptions
for lesser amounts as well as the right to reject in whole or in part subscriptions received during the Offering.

 

2.2Subscription.
The Investor hereby irrevocably subscribes to purchase from the Company, upon the terms and conditions stated in this Agreement,
that aggregate number of Shares for the Aggregate Purchase Price set forth on such Investor’s signature page to this Agreement.

 

2.3Investor Deliverables.
Promptly upon execution of this Agreement, the Investor agrees to deliver to Company (a) an executed Agreement, (b) a completed
Investor Suitability Questionnaire, attached hereto as Exhibit A to the Company (“Investor Suitability Questionnaire”),
and (c) the Aggregate Purchase Price set forth on such Investor’s signature page to this Agreement in United States dollars
and in immediately available funds, by wire transfer to the Company pursuant to the instructions provided by the Company (collectively,
referred to as the “Investor Deliverables”).

 

2.4Acceptance or Rejection of
Subscription. The Investor understands and agrees that the Company reserves the right, in its sole discretion, to reject this
subscription, in whole or in part if (a) the Investor is not an "accredited investor" or otherwise fails to meet the
investor suitability requirements as set forth in the Investor Suitability Questionnaire, (b) fails to deliver payment of the Aggregate
Purchase Price, or (c) fails to deliver a completed Investor Deliverables, until there has been notice of acceptance of the Investor’s
subscription. In the event of rejection of this subscription, the Investor’s funds (without interest) or, in the event of
a partial rejection a check in the amount of the rejected portion, will be promptly issued to the Investor.

 

    	 	 2	 

     

    

 

2.5Closing. The issuance
of up to 77,500,000 Shares shall take place promptly after the acceptance of the subscription by the Company and the Company has
received Investors Deliverables (the date on which such Shares are issued shall be referred to herein as the “Initial
Closing Date”); provided that if Investor is purchasing the Shares subsequent to the Initial Closing Date, the issuance
of the Shares shall occur upon payment of the Aggregate Purchase Price by Investor and acceptance of Investor’s Subscription
Agreement by the Company. The date on which the Shares are issued, whether on the Initial Closing Date or thereafter, shall be
referred to herein as the “Closing Date;” provided, however, that no sales to subsequent Investors may be made
after May 13, 2016, 5:00 pm (PST). Following the Closing Date, the Company will promptly deliver to the Investor:

 

(a)an "accepted"
Subscription Agreement; and

 

(b)the stock certificate
representing the number of Shares purchased by the Investor, as set forth on the Investor’s signature page to this Agreement.

 

2.5No Escrow or
Minimum Investment Amount. No escrow or minimum investment amount will be used for the offering.

 

ARTICLE III

REPRESENTATIONS AND WARRANTIES OF COMPANY

 

3.Representations
and Warranties of the Company. Except as disclosed in the SEC Documents and as otherwise stated to the contrary herein, the
Company hereby represents and warrants to the Investor as of the date hereof, and, if this Agreement is accepted by the Company
in whole or in part, will be true and correct on the Closing Date that:

 

3.1Authorization. All corporate
action on the part of the Company, its officers, directors and shareholders necessary for the authorization, execution and delivery
of this Agreement has been taken. The Company has the requisite corporate power to enter into this Agreement and carry out and
perform its obligations under the terms of this Agreement. The Company will have the requisite corporate power to issue and sell
the Shares. This Agreement has been duly executed and delivered by the Company and constitutes the valid and binding obligation
of the Company, enforceable against it in accordance with its terms, except (i) as limited by general equitable principles and
applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’
rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable
remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.

 

3.2Organization,
Good Standing and Qualification. The Company is a corporation duly organized, validly existing and in good standing under the
laws of the State of Nevada and has all requisite corporate power and authority to carry on its business as now conducted. The
Company is duly qualified to transact business and is in good standing in each jurisdiction in which the failure so to qualify
would have a Material Adverse Effect.

 

    	 	 3	 

     

    

 

3.3Outstanding Debt. Michael
Johnson, the Company’s director, is the director and sole shareholder of Esenjay. As part of this Offering, Esenjay, a controlling
shareholder of the Company which owns approximately 65% of the Company’s issued and outstanding Common Stock and our primary
credit line holder, has agreed to purchase an aggregate of 33,750,000 Shares in exchange for forgiveness of the Outstanding Debt.
Concurrently with the Initial Closing Date, Esenjay will execute a subscription agreement in substantially the form of this Agreement
to convert its Outstanding Debt into the Shares.

 

3.4Delivery of
SEC Documents; Business. The Company has made available to the Investor through the SEC’s EDGAR system, true and complete
copies of the Company’s most recent Annual Report on Form 10-K for the fiscal year ended June 30, 2015 and Form 10-Qs for
the quarters ended September 30, 2015 and December 31, 2015, and all other reports filed by the Company pursuant to the Exchange
Act since the filing of the Form 10-Q for the quarter ended December 31, 2015, and prior to the date hereof (collectively, the
“SEC Documents”). The Company is engaged in all material respects only in the business described in the SEC
Documents and the SEC Documents contain a complete and accurate description of the business of the Company in all material respects.

 

3.5No Conflict with Other Instruments.
The execution, delivery and performance of this Agreement, the issuance and sale of the Shares to be sold by the Company under
this Agreement and the consummation of the actions contemplated by this Agreement will not (a) result in any violation of, be in
conflict with, or constitute a material default under, with or without the passage of time or the giving of notice (i) any provision
of the Company’s Articles of Incorporation, as amended, or Bylaws, as amended (or similar governing documents); (ii) any
provision of any judgment, arbitration ruling, decree or order to which the Company is a party or by which the Company is bound;
or (iii) any bond, debenture, note or other evidence of indebtedness, or any material lease, contract, mortgage, indenture, deed
of trust, loan agreement, joint venture or other agreement, instrument or commitment to which the Company is a party or by which
the Company or its properties is bound; or (b) result in the creation or imposition of any lien, encumbrance, claim, security interest
or restriction whatsoever upon any of the properties or assets of the Company or any acceleration of indebtedness pursuant to any
obligation, agreement or condition contained in any bond, debenture, note or any other evidence of indebtedness or any indenture,
mortgage, deed of trust or any other agreement or instrument to which the Company is a party or by which the Company is bound or
to which any of the property or assets of the Company is subject.

 

3.6Capitalization. As of
April 15, 2015, the authorized capital stock of the Company consists of (a) 300,000,000 shares of Common Stock, of which (i) 150,935,137
shares are issued and outstanding, and (b) 71,564,863 shares are reserved for issuance upon the exercise or conversion, as the
case may be, of outstanding options, warrants or other convertible securities; and (c) 5,000,000 shares of preferred stock, none
of which, are outstanding or reserved for issuance upon the exercise or conversion, as the case may be, of outstanding options,
warrants or other convertible securities. Except as disclosed in the Company SEC Documents and set forth in the Company’s
Articles of Incorporation, as amended and contemplated in the Transaction Documents, there are no anti-dilution or price adjustment
provisions, co-sale rights, registration rights, rights of first refusal or other similar rights contained in the terms governing
any outstanding security of the Company that will be triggered by the issuance of the Shares.

 

3.7Valid Issuance
of the Shares. The Shares will be duly and validly authorized and, when issued and paid for pursuant to this Agreement, will
be validly issued, fully paid and non-assessable, and shall be free and clear of all encumbrances and restrictions (other than
those created by the Investor), except for restrictions on transfer set forth in this Agreement or imposed by applicable securities
laws.

 

    	 	 4	 

     

    

 

 3.8Litigation.
Except as set forth in the Company SEC Documents, there is no action, suit, proceeding nor investigation pending or, to the
Company’s knowledge, currently threatened against the Company that (a) if adversely determined would reasonably be expected
to have a Material Adverse Effect or (b) would be required to be disclosed in the Company’s Annual Report on Form 10-K under
the requirements of Item 103 of Regulation S-K. The foregoing includes, without limitation, any action, suit, proceeding or investigation,
pending or threatened, that questions the validity of this Agreement or the right of the Company to enter into such Agreement
and perform its obligations hereunder. The Company is not subject to any injunction, judgment, decree or order of any court, regulatory
body, arbitral panel, administrative agency or other government body.

 

3.9Governmental
Consents. No consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing
with, any federal, state, local or provincial governmental authority on the part of the Company is required in connection with
the consummation of the transactions contemplated by this Agreement, except for notices required or permitted to be filed with
certain state and federal securities commissions, which notices will be filed on a timely basis.

 

3.10 No Material
Changes. Except as disclosed in the Company SEC Documents and since December 31, 2015, there has not been any material change
that has had a Material Adverse Effect.

 

3.11 Investment
Company. The Company is not an “investment company” or an “affiliated person” of, or “promoter”
or “principal underwriter” for an investment company, within the meaning of the Investment Company Act of 1940 and
will not be deemed an “investment company” as a result of the transactions contemplated by this Agreement.

 

3.12 No General
Solicitation. Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf, has engaged or
will engage in any form of general solicitation or general advertising (within the meaning of Regulation D promulgated under the
Securities Act) in connection with the offer or sale of the Shares.

 

3.13Placement Agent. The
Company may retained registered broker-dealers as its placement agent (“Selling Agent(s)”). In general, any
agreements entered into with Selling Agent(s) will be on a “best efforts” basis and the fees to be paid will be capped
at 6% of the subscription attributable to the Selling Agent(s).

 

ARTICLE IV

REPRESENTATIONS AND WARRANTIES OF INVESTOR

 

4.Representations and Warranties
of the Investor. The Investor hereby represents and warrants to the Company as follows

 

4.1Organization,
Authority If the Investor is an entity, such Investor is a corporation, partnership, limited liability company or partnership,
association, joint stock company, trust, unincorporated organization or other entity duly organized, validly existing and in good
standing under the laws of the jurisdiction of its organization with the requisite corporate, partnership or other power and authority
to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise to carry out its obligations
hereunder and thereunder. The purchase by such Investor of the Securities hereunder has been, to the extent such Investor is an
entity, duly authorized by all necessary corporate, partnership or other action on the part of such Investor. This Agreement has
been duly executed and delivered by such Investor and constitutes the valid and binding obligation of such Investor, enforceable
against it in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency,
reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally, (ii)
as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii)
insofar as indemnification and contribution provisions may be limited by applicable law.

 

    	 	 5	 

     

    

 

4.2Investment
Representations. In connection with the sale and issuance of the Shares, the Investor, for itself and no other Investor, makes
the following representations:

 

(a)Investment
for Own Account. The Investor is acquiring the Shares for its own account, not as nominee or agent, and not with a view to,
or for resale in connection with, any distribution or public offering thereof within the meaning of the Securities Act. The Investor
has no present intention of selling, granting any participation in, or otherwise distributing the Shares. The Investor does not
have any contract, undertaking, agreement or arrangement with any person to sell, transfer or grant participation in any of the
Shares to such person or to any third person.

 

(b)SEC Documents;
Disclosure Materials. The Investor has received, read and fully understands the SEC Documents and the Disclosure Material.
The Investor acknowledges that the Investor is basing its decision to invest in the Shares on the Disclosure Material and the exhibits
thereto and has relied only on the information contained in said material and has not relied upon any representations made by any
other person. The Investor recognizes that an investment in the Shares involves substantial risks and is fully cognizant of and
understands all of the risk factors related to the purchase of the Shares, including but not limited to, those risks set forth
in the section of the SEC Documents and Disclosure Materials entitled “RISK FACTORS.”

 

(c)Investor
Status. At the time such Investor was offered the Shares, it was, at the date hereof it is, and on the date which it exercises
any Warrants it will be an “accredited investor” as defined in Rule 501(a) under the Securities Act or a “qualified
institutional buyer” as defined in Rule 144A(a) under the Securities Act. Such Investor is not a registered broker dealer
registered under Section 15(a) of the Exchange Act, or a member of the Financial Industry Regulatory Authority, Inc. (“FINRA”)
or an entity engaged in the business of being a broker dealer. Such Investor is not affiliated with any broker dealer registered
under Section 15(a) of the Exchange Act, or a member of FINRA or an entity engaged in the business of being a broker dealer.

 

(d)Representations
and Reliance. The Investor understands that the Shares are being offered and sold to it in reliance on specific exemptions
from the registration requirements of the United States federal and state securities laws and that the Company is relying upon
the truth and accuracy of the representations, warranties, agreements, acknowledgments and understandings of the Investor set forth
herein and in the Investor Suitability Questionnaire to determine the applicability of such exemptions and the suitability of the
Investor to acquire the Shares. All information which the Investor has provided to the Company, including but not limited to all
information given herein and in the Investor Suitability Questionnaire or otherwise, concerning itself, investor status, address,
residence, financial position and knowledge and experience of financial and business matters are correct and complete, and that
if there should be any material change in such information the Investor will immediately provide the Company with such information.
The Investor will promptly notify the Company of any material fact or circumstance that would cause any of the foregoing representations
to be untrue, incomplete, or misleading.

 

(e)Restricted
Securities. The Investor understands that the Shares the Investor is purchasing are characterized as “restricted securities”
under the federal securities laws inasmuch as they are being acquired from the Company in a transaction not involving a public
offering and that under such laws and regulations such securities may be resold without registration under the Securities Act only
in certain limited circumstances. The Investor is familiar with Rule 144, as presently in effect, and understands the resale limitations
imposed thereby and by the Securities Act. The Investor also acknowledges that the Company was a former “shell company”
(as defined in Rule 12b-2 under the Exchange Act) and as such the Investor understands Rule 144 is not currently available for
the sale of the Shares and may never be so available.

 

    	 	 6	 

     

    

 

(f)Transfer
Restrictions; Legends. The Investor understands that (i) the Shares have not been registered under the Securities Act; (ii)
the Shares are being offered and sold pursuant to an exemption from registration, based in part upon the Company’s reliance
upon the statements and representations made by the Investor, and that the Shares must be held by the Investor indefinitely, and
that the Investor must, therefore, bear the economic risk of such investment indefinitely, unless a subsequent disposition thereof
is registered under the Securities Act or is exempt from such registration; and (iii) each Certificate representing the Shares
will be endorsed with a legend substantially in the following form until the earlier of (1) such date as the Shares have been registered
for resale by the Investor or (2) the date the Shares are eligible for sale under Rule 144.

 

THE SECURITIES REPRESENTED HEREBY HAVE
NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER THE SECURITIES
LAWS OF ANY STATES. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD
EXCEPT AS PERMITTED UNDER THE SECURITIES ACT AND THE APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM.
UNLESS SOLD PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT, THE ISSUER OF THESE SECURITIES MAY REQUIRE
AN OPINION OF COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER TO THE EFFECT THAT ANY PROPOSED TRANSFER OR RESALE IS IN
COMPLIANCE WITH THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS.

 

(g)Limited
Public Market. The Investor understands and acknowledges that there is only a limited public market for our Common Shares on
the OTCQB, and which market is very volatile, and the Company has made no assurances that a broader or more active public trading
market for our Common Shares will ever exist.

 

(h)No Transfer.
The Investor covenants not to dispose of any of the Shares other than in conjunction with an effective registration statement under
the Securities Act or in compliance with Rule 144 or pursuant to another exemption from registration or to an entity affiliated
with the Investor and other than in compliance with the applicable securities regulations laws of any state.

 

(i)Investment
Experience. Investor acknowledges that the Investor is able to bear the economic risk of the Investor’s investment, including
the complete loss thereof. The Investor has a preexisting personal or business relationship with the Company or one or more of
its officers, directors or other persons in control of the Company, and the Investor has such knowledge and experience in financial
or business matters that it is capable of evaluating the merits and risks of the investment in the Shares.

 

(j)Financial
Sophistication; Due Diligence. The Investor has such knowledge and experience in financial or business matters that it is capable
of evaluating the merits and risks of the investment in connection with the transactions contemplated in this Agreement. Such Investor
has, in connection with its decision to purchase the Shares, relied only upon the representations and warranties contained herein
and the information contained in the Company’s SEC Documents. Further, the Investor has had such opportunity to obtain additional
information and to ask questions of, and receive answers from, the Company, concerning the terms and conditions of the investment
and the business and affairs of the Company, as the Investor considers necessary in order to form an investment decision.

 

(k)General
Solicitation. The Investor is not purchasing the Shares as a result of any advertisement, article, notice or other communication
regarding the Shares published in any newspaper, magazine or similar media or broadcast over the television or radio or presented
at any seminar or any other general solicitation or general advertisement. Prior to the time that the Investor was first contacted
by the Company or either of the Agents such Investor had a pre-existing and substantial relationship with the Company or one of
the Agents. The Investor will not issue any press release or other public statement with respect to the transactions contemplated
by this Agreement without the prior written consent of the Company. Other than to other parties to this Agreement, the Investor
has maintained and will continue to maintain the confidentiality of all disclosures made to Investor in connection with this transaction,
including the existence and terms of this transaction.

 

    	 	 7	 

     

    

 

4.3No Investment,
Tax or Legal Advice. The Investor understands that nothing in the Company SEC Documents, this Agreement, or any other materials
presented to the Investor in connection with the purchase and sale of the Shares constitutes legal, tax or investment advice. The
Investor has consulted such legal, tax and investment advisors as it, in its sole discretion, has deemed necessary or appropriate
in connection with its purchase of Shares.

 

4.4Disclosure
of Information. The Investor understands that no United States federal or state agency or any other government or governmental
agency has passed upon or made any recommendation or endorsement of the Shares. The Investor has reviewed the documents publicly
filed by the Company with the SEC and has read and understands the risk factors disclosed therein. The Investor has received all
the information it considers necessary or appropriate for deciding whether to purchase the Shares. The Investor is solely responsible
for conducting its own due diligence investigation of the Company.

 

4.5Additional
Acknowledgement. The Investor acknowledges that it has independently evaluated the merits of the transactions contemplated
by this Agreement, that it has independently determined to enter into the transactions contemplated hereby, that it is not relying
on any advice from or evaluation by any other person. The Investor acknowledges that, if it is a client of an investment advisor
registered with the SEC, the Investor has relied on such investment advisor in making its decision to purchase Shares pursuant
hereto.

 

4.6Subscription
Rejection Right. The Investor acknowledges that the Company reserves the right to reject any subscription, to accept any subscription
in part only, or to prorate subscriptions, to negotiate any checks or other tenders of payment for discrepant amounts and to refund
the excess to the Investor if (a) the Investor is not an "accredited investor" or otherwise fails to meet the investor
suitability requirements as set forth in the Investor Suitability Questionnaire, (b) fails to deliver payment of the Aggregate
Purchase Price, or (c) fails to deliver the completed Investor Deliverables substantially in the form as reasonably acceptable
to the Company.

 

4.7No Short Position
As of the date hereof, and from the date hereof through the date of the Closing Date, the Investor acknowledges and agrees that
it does not and will not (between the date hereof and the Closing Date) engage in any short sale of the Company’s voting
stock or any other type of hedging transaction involving the Company’s securities (including, without limitation, depositing
shares of the Company’s securities with a brokerage firm where such securities are made available by the broker to other
customers of the firm for purposes of hedging or short selling the Company’s securities).

 

    	 	 8	 

     

    

 

ARTICLE V

ADDITIONAL COVENANTS

 

5.Additional Covenants.

 

5.1Confidential Information.
The Investor covenants that it will maintain in confidence the receipt and content of any information provided in connection with
this Agreement until such information (a) becomes generally publicly available other than through a violation of this provision
by the Investor or its agents or (b) is required to be disclosed in legal proceedings (such as by deposition, interrogatory, request
for documents, subpoena, civil investigation demand, filing with any governmental authority or similar process); provided, however,
that before making any disclosure in reliance on this Section 5.1, the Investor will give the Company at least 15 days prior written
notice (or such shorter period as required by law) specifying the circumstances giving rise thereto and the Investor will furnish
only that portion of the non-public information which is legally required and will exercise its best efforts to ensure that confidential
treatment will be accorded any non-public information so furnished; provided, further, that notwithstanding, the Investor’s
agreement to keep such information confidential, the Investor makes no such acknowledgement that any such information is material,
non-public information.

 

5.2Transfer Restrictions.
The Investor covenants that the Shares will only be disposed of pursuant to an effective registration statement under, and in compliance
with the requirements of, the Securities Act or pursuant to an available exemption from the registration requirements of the Securities
Act, and in compliance with any applicable state securities laws. In connection with any transfer of Shares other than pursuant
to an effective registration statement or to the Company, or at such time that the Shares may be sold without the requirement to
be in compliance with Rule 144(c)(1) and otherwise without restriction or limitation pursuant to Rule 144, the Company may require
the transferor to provide to the Company an opinion of counsel selected by the transferor, the form and substance of which opinion
shall be reasonably satisfactory to the Company, to the effect that such transfer does not require registration under the Securities
Act. The Investor agrees to the imprinting of the restrictive legend in substantially the form set forth in Section 4.2(f).

 

ARTICLE VI

MISCELLANEOUS

 

6.Miscellaneous.

 

6.1Governing Law.
This Agreement shall be governed by and construed in accordance with the laws of the State of California, without regard to the
choice of law provisions thereof, and the federal laws of the United States.

 

6.2Successors
and Assigns. Except as otherwise expressly provided herein, the provisions hereof shall inure to the benefit of, and be binding
upon, the successors, assigns, heirs, executors, and administrators of the parties hereto.

 

6.3Entire Agreement.
This Agreement and the exhibits hereto, and the other documents delivered pursuant hereto, constitute the full and entire understanding
and agreement among the parties with regard to the subjects hereof and no party shall be liable or bound to any other party in
any manner by any representations, warranties, covenants, or agreements except as specifically set forth herein or therein. Nothing
in this Agreement, express or implied, is intended to confer upon any party, other than the parties hereto and their respective
successors and assigns, any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly
provided herein.

 

    	 	 9	 

     

    

 

6.4Severability.
In the event any provision of this Agreement shall be invalid, illegal, or unenforceable, it shall to the extent practicable, be
modified so as to make it valid, legal and enforceable and to retain as nearly as practicable the intent of the parties, and the
validity, legality, and enforceability of the remaining provisions shall not in any way be affected or impaired thereby.

 

6.5Amendment and
Waiver. Except as otherwise provided herein, any term of this Agreement may be amended, modified, supplemented and the observance
of any term of this Agreement may be waived (either generally or in a particular instance, either retroactively or prospectively,
and either for a specified period of time or indefinitely), with the written consent of the Company and the holders of a majority
of the Common Shares sold in this Offering. Any amendment or waiver effected in accordance with this paragraph will be binding
upon each holder of any Shares purchased under this Agreement, each future holder of the Shares, and the Company.

 

6.6Fees and Expenses.
Except as otherwise set forth herein, the Company and the Investor shall bear their own expenses and legal fees incurred on their
behalf with respect to this Agreement and the transactions contemplated hereby. Each party hereby agrees to indemnify and to hold
harmless of and from any liability the other party for any commission or compensation in the nature of a finder’s fee to
any broker or other person or firm (and the costs and expenses of defending against such liability or asserted liability) for which
such indemnifying party or any of its employees or representatives are responsible.

 

6.7Notices.
All notices and other communications given or made pursuant to this Warrant Certificate shall be in writing and shall be deemed
effectively given upon the earlier of actual receipt or (i) personal delivery to the party to be notified, (ii) when sent, if sent
by electronic mail or facsimile during normal business hours of the recipient, and if not sent during normal business hours, then
on the recipient’s next Business Day, (iii) five (5) days after having been sent by registered or certified mail, return
receipt requested, postage prepaid, or (iv) one (1) Business Day after deposit with a nationally recognized overnight courier,
freight prepaid, specifying next Business Day delivery, with written verification of receipt. All communications shall be sent
to the respective parties at the address indicated for such party in the Purchase Agreement, or at such other address as such party
may designate by 10 days advance written notice to the other party given in the foregoing manner:

 

	if to the Company, to:	Flux Power Holdings, Inc.
	 	985 Poinsettia Avenue
	 	Vista, California 92081
	 	Fax (760) 741-3535
	 	Attn: President

 

if to the Investor, at its address on the signature
page to this Agreement.

 

6.8Survival of Representations,
Warranties and Agreements. Notwithstanding any investigation made by any party to this Agreement or by any of the Agents, all
covenants, agreements, representations and warranties made by the Company and the Investor herein shall survive the execution of
this Agreement, the delivery to the Investor of the Shares being purchased and the payment therefor, and a party’s reliance
on such representations and warranties shall not be affected by any investigation made by such party or any information developed
thereby.

 

6.9Counterparts. This Agreement
may be executed by facsimile signature and in any number of counterparts, each of which shall be deemed an original, but all of
which together shall constitute one instrument.

 

    	 	 10	 

     

    

 

SUBSCRIPTION AGREEMENT
SIGNATURE PAGE

 

In addition to the
foregoing, Investor hereby certifies that it (a) agrees to all the terms and conditions of this Agreement, (b) meets the suitability
standards set forth in this Agreement, and (c) is a resident of the state and jurisdiction indicated below.

 

	Date: 5/5/16	Name
    of Investor:	 
	 	 	 
	 	Esenjay
    Investments,  LLC	 
	 	Entity
    Name (if any)	 
	 	 	 	 
	 	By: 	/s/
    Michael Johnson	 
	 		Name:  Michael Johnson	 
	 	 	Title:  President	 

 

	 	Address: 	 	 
	 	 	 	 
	 	State of Principal Residence: 	 	 
	 	 	 	 
	 	State of Incorporation/Organization: 	 	 
	 	 	 	 
	 	EIN/Social Security Number:	 	 
	 	 	 	 
	 	Telephone No.:	 	 
	 	 	 	 
	 	Facsimile No.: 	 	 
	 	 	 	 
	 	Email Address:	 	 
	 	 	 	 
	 	Number of Shares:	33,750,000	 
	 	 	 	 
	 	Aggregate Purchase Price : 	$1,350,000	 

 

Delivery Instructions (if different than
above):

 

	c/o: 	 	 
	 	 	 
	Address: 	 	 
	 	 	 
	Telephone No.:	 	 
	 	 	 
	Facsimile No. :	 	 
	 	 	 
	Other Special Instructions: 	 	 

  

    	 	 11	 

     

    

 

SUBSCRIPTION ACCEPTED

 

	Date: 5/5/2016	FLUX POWER HOLDINGS, INC.	 
	 	 	 	 
	 	 	 	 
	 	By: 	/s/ Ronald Dutt	 
	 	Name: 	Ronald Dutt	 
	 	Title: 	Chief Executive Officer and Acting Chief

 Financial Officer	 

 

    	 	 12Exhibit 10.2

 

AMENDMENT TO SEPARATION AGREEMENT 

 

This Amendment to the Separation Agreement
(this "Amendment") is effective as of the 1st day of January, 2016,
between Enzon Pharmaceuticals, Inc., a Delaware corporation, with offices in Piscataway, New Jersey (the "Company"),
and Andrew Rackear (the “Executive").

 

BACKGROUND

 

A.           This
Amendment constitutes the amended agreement between the Company and the Executive concerning certain terms set forth in the Separation
Agreement entered into between the Company and the Executive dated September 27, 2013 (the “Separation Agreement”).

 

B.           The
Company desires to continue to ensure that it can rely on the continued services of the Executive to assist with a transition in
the business of the Company, in order to avoid potentially material liabilities, obligations or losses that might arise from such
transition if the Company is not able to rely on employees who have experience with the operations of the Company.

 

C.           The
Executive desires to continue to assure himself of financial support following the termination of his employment with the Company.

 

TERMS

 

In consideration of the foregoing premises
and for other good and valuable consideration, the Company and Executive agree as follows:

 

1.
  The fee set forth in paragrapgh 5 of the Separation Agreement is changed from $250 per hour to $285 per hour.

 

2.   All other terms and conditions shall
remain the same.

 

IN WITNESS WHEREOF, the
parties hereto have executed this Amendment as of the date first set forth above.

 

	 	ENZON PHARMACEUTICALS, INC.
	 	 
	 	/s/ Jennifer McNealey
	 	By: Jennifer McNealey
	 	Dated:
	 	 
	 	/s/ Andrew Rackear
	 	ANDREW RACKEAR
	 	Dated:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00258-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00258-of-00352.parquet"}]]